Related Experiment Video
Updated: Jul 28, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Risk factors not addressed in antihypertensive therapy based solely on blood pressure control
J Somberg1, S Ehrenpreis, G Shroff
1Department of Medicine, Chicago Medical School, North Chicago, Illinois 60064.
Insights
Hypertension therapy has dramatically improved life expectancy and reduced stroke incidence. New drug classes offer potential for further reducing coronary artery disease mortality in hypertensive patients.
Area of Science:
- Cardiology
- Pharmacology
- Public Health
Background:
- Severe and accelerated hypertension previously led to short life expectancy.
- Stroke was a common outcome of hypertensive cardiovascular disease.
Purpose of the Study:
- To review the evolution of hypertension therapy.
- To discuss the potential of new drug classes in managing cardiovascular risk.
- To explore strategies for reducing coronary artery disease mortality in hypertensive patients.
Main Methods:
- Review of historical trends in hypertension management.
- Discussion of recent advancements in antihypertensive drug development.
- Analysis of theoretical benefits of new agents on metabolic and hemodynamic risk factors.
Main Results:
- Blood pressure control has significantly improved longevity.
- Effective hypertension treatment has markedly reduced stroke incidence.
- New drug classes show theoretical promise for reducing coronary heart disease risk.
Conclusions:
- While stroke risk is reduced, coronary artery disease mortality remains a challenge in hypertension.
- Emerging antihypertensive agents may offer superior cardiovascular protection.
- Personalized therapy selection is crucial for optimizing outcomes in hypertensive patients.
Abstract:
There has been a considerable revolution in the field of hypertension therapy. We have gone through an era in which patients with severe hypertension and those with accelerated hypertension had a very short life expectancy. Currently blood pressure can be readily controlled with a marked improvement in longevity. We have gone from an era in which stroke was common due to hypertensive cardiovascular disease to an era in which patients are effectively treated and there has been a marked reduction in the incidence of stroke. The challenge is whether we can reduce the very high mortality due to coronary artery disease in patients with hypertension as we have done with stroke. New groups of drugs that may have a more favorable effect on metabolic and hemodynamic risk considerations have been developed over the last decade. These agents may reduce the risk for coronary heart disease to a greater extent than previously employed therapy. While there are no randomized placebo-controlled studies demonstration this, a theoretical basis does exist to give the physician reason to think about prioritizing therapies and tailoring them to the needs of the individual patient.
More Related Videos
Related Concept Videos
Factors affecting Blood pressure
Physiological Factors:
Hypertension and Regulation of Blood Pressure
Hypertension I: Introduction
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension IV: Drug Therapy and Lifestyle Modifications

